November 10, 2011

Genzyme has named leaders of two units that are part of the core focus of the drug maker's business.

November 10, 2011

The Food and Drug Administration has accepted a new drug application for a skin cancer treatment developed by Roche.

November 10, 2011

Walgreens now has certified more than 500 of its pharmacies as HIV Centers of Excellence in communities highly impacted by HIV, as identified by the Centers for Disease Control and Prevention, the pharmacy operator announced Thursday at the U.S. Conference on AIDS.

November 9, 2011

Diplomat Specialty Pharmacy was recognized by MichBio, a biosciences industry trade association and the official Michigan affiliate of the Biotechnology Industry Organization.

November 8, 2011

Specialty pharmacy provider BioScrip reported $454 million in sales and $500,000 in profits in third quarter 2011, according to an earnings statement released Tuesday.

November 8, 2011

The Food and Drug Administration on Tuesday launched a website for patients and caregivers on the safe disposal of needles and other “sharps” that are used at home, at work and while traveling.

November 8, 2011

Purdue Pharma has launched a new way for fighting pharmacy crime, the drug maker said Tuesday.

November 8, 2011

The University of Arizona Cancer Center, in partnership with Walgreens, last month opened a specialty outpatient pharmacy on-site to meet the needs of its patients.

November 7, 2011

A large number of patients with a serious form of arthritis experienced improvement in their condition after taking a drug made by Abbott Labs for three months, according to results of a late-stage clinical trial announced Monday.

November 7, 2011

The Food and Drug Administration has appointed a new chief of staff for commissioner Margaret Hamburg, according to a letter sent to agency employees Monday.

November 7, 2011

The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for treating head and neck cancer, the agency said Monday.

November 7, 2011

A new report from the Food and Drug Administration indicated that Roche division Genentech may not have followed proper procedures to prevent the contamination of certain drugs, according to published reports.

November 4, 2011

The Food and Drug Administration has cleared the way for the return to market of a drug for treating immunodeficiency diseases following its recall by the manufacturer in response to patients developing internal blood clots.

November 3, 2011

Drug maker Bristol-Myers Squibb will present 20 study abstracts at the American College of Rheumatology Annual Scientific Meeting in Chicago, the company said Thursday.

November 3, 2011

The Food and Drug Administration has approved 35 new drugs over the past 12 months, the agency said Thursday.

November 2, 2011

AmerisourceBergen on Tuesday recorded revenues of $20.4 billion for fourth quarter 2011 ended Sept. 30, up 3.5%. Diluted earnings per share increased 8% to 54 cents. For the year, AmerisourceBergen posted $80.2 billion in revenue, up 2.9%.

November 2, 2011

CareFirst BlueCross BlueShield and Cardinal Health Specialty Solutions on Tuesday launched the nation's first clinical pathways program for rheumatoid arthritis, a chronic disease that leads to inflammation of the joints and surrounding tissue and affects nearly 2.1 million Americans each year.

November 2, 2011

The Food and Drug Administration has approved changes to the labeling of a cancer drug made by Takeda Pharmaceuticals, the drug maker said.

November 1, 2011

Pfizer soon may lose its distinction of having the highest global sales of any drug company, according to life sciences industry analysis firm EvaluatePharma.

October 31, 2011

Watson Pharmaceuticals and a partnering company are barred from launching a generic version of a blood-thinning drug under a federal court decision issued Friday.

October 31, 2011

President Barack Obama issued an executive order Monday to address the growing problem of drug shortages.

October 28, 2011

Icagen officially is a wholly owned subsidiary of Pfizer.

October 27, 2011

Drug makers Bristol-Myers Squibb and Gilead Sciences announced an agreement to develop and commercialize a fixed-dose combination treatment for patients with HIV.

October 27, 2011

An experimental vaccine for hepatitis B made by Dynavax Technologies appears to work better in patients with diabetes than current treatments, the company said.